Are Nicotine Salts Safe? What the Research Says

Nicotine salts are not proven safe in any absolute sense, and no health authority has declared them harmless. What research does show is a mixed picture: compared to combustible cigarettes, switching to nicotine salt devices dramatically reduces exposure to the most dangerous toxicants in tobacco smoke, but the salts introduce their own concerns, particularly around inflammation, oxidative stress, and the ease with which high nicotine concentrations can be inhaled. The chemistry that makes nicotine salts smooth enough to inhale comfortably at 50 mg/mL or more is the same chemistry that makes them more addictive and potentially more biologically reactive than older e-cigarette formulations.

What Nicotine Salts Actually Are

Traditional e-cigarettes used freebase nicotine, which is nicotine in its pure, unprotonated form. At high concentrations, freebase nicotine is harsh and irritating to the throat, which effectively capped how much nicotine an e-liquid could practically contain. Nicotine salts solve that problem by combining nicotine with an organic acid, most commonly benzoic acid. This reaction creates a protonated form of nicotine that sits at a lower pH, typically in the 5 to 6 range.¹ The protonated nicotine is far less irritating when inhaled, which allows manufacturers to pack concentrations of 50 mg/mL or higher into small pod devices. For reference, many older tank-style e-cigarettes used freebase nicotine at 3 to 12 mg/mL.

This shift toward nicotine salts was popularized by JUUL around 2015 and has since spread across the vaping industry, including disposable devices and refillable pod systems. The smoothness is not just a comfort feature; it fundamentally changes how the product is used, who finds it tolerable, and how much nicotine reaches the bloodstream.

How Nicotine Salts Change What Reaches Your Blood

The pharmacokinetic profile of nicotine salts is one of the most studied aspects of these products, and the findings explain a lot about both their appeal and their risk. In a randomized crossover study, participants who vaped a 40 mg/mL nicotine salt solution reached a median peak blood nicotine level of 12.0 ng/mL, compared to 5.4 ng/mL for a 20 mg/mL salt and just 3.0 ng/mL for a 20 mg/mL freebase nicotine liquid.² All groups reached peak levels within about two minutes of their last puff, meaning nicotine salts deliver a fast spike, not a slow build.

A separate clinical study found that while nicotine salt e-cigarettes could match the speed of nicotine absorption from a conventional cigarette, they did not exceed the total nicotine delivery of a cigarette in any tested configuration.³ That finding is important context: nicotine salt pods mimic the cigarette-like speed of delivery that smokers crave, without overshooting the cigarette’s peak. The concern is that this cigarette-like pharmacokinetic profile also preserves much of the cigarette’s addictive potential.

Animal data adds another layer. In rats given nicotine subcutaneously, freebase nicotine actually maintained a higher sustained concentration in the body over time, while nicotine benzoate (the most common salt form) showed lower peak plasma levels as the ratio of benzoic acid increased.⁴ This matters because it suggests the acid-to-nicotine ratio in a given product can meaningfully alter how much nicotine ultimately circulates. Not all nicotine salt products are pharmacologically identical.

Why Smoothness Is a Safety Issue

One of the least intuitive findings in this area is that the pleasant user experience of nicotine salts is itself a health concern. In a randomized clinical trial, participants rated nicotine salt formulations significantly higher in appeal, sweetness, and smoothness compared to freebase nicotine, while rating them lower in bitterness and harshness.⁵ The smoothness difference was striking: salt formulations scored an average of about 64 on a smoothness scale, compared to about 46 for freebase.

That smoothness is not cosmetic. An evidence review found that acid additives, including the ones used to create nicotine salts, reduce harshness and increase blood nicotine yield, while sweet or fruity flavors reduce perceived bitterness and increase attractiveness.⁶ In plain terms, the smoother a product feels, the deeper and more frequently you can inhale, and the more nicotine you absorb. For someone trying to quit cigarettes, that mimicry can be helpful. For someone who has never smoked, that low barrier to entry becomes a gateway to dependence.

What Happens in the Lungs

The cellular-level evidence on nicotine salts and lung tissue is where the picture gets complicated, because results depend heavily on what you compare them to and which salt form you test.

When researchers exposed lung epithelial cells to aerosols from a fourth-generation pod device, nicotine benzoate and nicotine salicylate both triggered substantially more inflammation than freebase nicotine. Cells exposed to nicotine benzoate produced roughly 35% more of the inflammatory marker IL-8 than freebase, while nicotine salicylate caused about a 50% increase. On top of that, nicotine benzoate also caused a significant 1.6-fold increase in a marker of oxidative DNA damage compared to freebase nicotine.⁷ Cell survival was similar across all three forms, so it is not that salt forms are killing cells faster; they are provoking more inflammatory and oxidative responses in living tissue.

A separate study using human nasal epithelial cells found a different pattern depending on whether the cells came from smokers or nonsmokers. Freebase nicotine exposure increased mucus production in cells from nonsmokers, while nicotine salt exposure did not. But in cells from smokers, nicotine salt triggered an increase in pro-inflammatory cytokines that freebase nicotine did not.⁸ The takeaway is that the biological response to nicotine salts depends on the individual’s history, and broad claims about one form being universally “safer” than another are premature.

Research on JUUL e-liquids specifically found significant cytotoxic effects, with the Mint flavor being the most toxic to cells. That study also confirmed that e-liquids permeated into living cells and directly exposed intracellular structures, including the endoplasmic reticulum.⁹ The researchers proposed that nicotine salt e-liquids exert biological effects beyond what nicotine alone would cause, and that flavor-specific toxicity needs much more attention.

One study examining airway barrier function found that freebase nicotine actually caused stronger barrier disruption than nicotine salicylate under identical conditions.¹⁰ This finding cuts against a simple narrative that salts are always worse for lung tissue. The reality is that different endpoints tell different stories: freebase may do more direct structural damage, while salts provoke more inflammation and oxidative stress.

The Benzoic Acid Problem

Benzoic acid is the most commonly used acid in nicotine salt formulations, and it introduces a concern that goes beyond nicotine itself. When benzoic acid is heated during vaping, it can break down to form benzene, a known human carcinogen. Lab testing found that with benzoic acid at concentrations around 10 mg/mL in tank-style devices, benzene levels reached as high as 5,000 micrograms per cubic meter at higher power settings.¹¹ For context, workplace exposure limits for benzene are typically set far below that level.

Pod devices generally operate at lower power than the tank systems used in that study, which reduces but does not eliminate benzene formation. A related study confirmed that when nicotine benzoate is dissolved in the standard propylene glycol and vegetable glycerin mixture, aerosolization produces phenols, which are another class of irritant compounds, likely formed through chemical reactions of the heated humectants or their breakdown products.¹²

Research on how device hardware affects these emissions shows that lower-resistance coils reach higher temperatures and produce more aerosol mass, a relationship that holds in fourth-generation pod devices just as it does in older models.¹³ Higher temperatures mean more thermal degradation of e-liquid ingredients, which means more potentially harmful byproducts. A user who buys a pod device with a lower-resistance coil is, whether they know it or not, likely inhaling more carbonyls and other degradation products per puff.

A broader concern noted by researchers is that the interactions between multiple e-liquid ingredients at high temperatures remain poorly understood. The potential for synergistic toxicity, where two individually mild chemicals become harmful together, is largely uninvestigated in e-cigarette formulations.

Effects on the Heart

Nicotine itself, regardless of delivery method, acutely raises heart rate and blood pressure. E-cigarette aerosol exposure does this in a pattern similar to smoking a conventional cigarette.¹⁴ A study of 110 participants, including exclusive e-cigarette users, cigarette smokers, and nonusers, found that acute nicotine e-cigarette use increased heart rate, blood pressure, and produced changes in heart rate variability suggestive of increased sympathetic nervous system activity. All nicotine-containing exposures, whether from e-cigarettes or combustible cigarettes, significantly increased heart rate and blood pressure compared to nicotine-free exposures.¹⁵

The researchers noted that because e-cigarettes produced hemodynamic increases similar to those from cigarettes, and because chronic e-cigarette users showed an abnormal heart rate variability pattern associated with elevated cardiac sympathetic tone, the role of these devices in harm reduction deserves scrutiny. This does not mean e-cigarettes are as cardiovascularly dangerous as cigarettes over the long term, since cigarette smoke carries thousands of additional toxicants. But it does mean that nicotine salt devices, which deliver nicotine at cigarette-like speed and concentrations, are not cardiovascularly inert.

Addiction and Dependence

The combination of high nicotine concentration, fast absorption, and smooth inhalation creates a product with strong dependence potential. A study of undergraduates who used JUUL found that those vaping six or more days per month had nearly five times the odds of showing dependence symptoms compared to less frequent users, and those who finished a pod within a week or less had up to six times the odds of reporting craving-related dependence symptoms.¹⁶

The frequency and quantity of use both independently predicted dependence across multiple validated scales. This is consistent with what pharmacology would predict: a product that delivers nicotine quickly and in high doses, while feeling pleasant to use, creates strong reinforcement. The smoothness of nicotine salts removes the body’s natural aversion signal, the throat burn that would otherwise limit intake, essentially disabling a built-in safety mechanism.

How Nicotine Salts Compare to Cigarettes on Toxicant Exposure

If you are an adult smoker considering switching to a nicotine salt device, the biomarker evidence is the most directly relevant data. In a five-day study, smokers who switched completely to a nicotine salt pod system showed an aggregate reduction of about 85% in eight non-nicotine biomarkers of exposure, measured in urine. That reduction was statistically indistinguishable from the reduction seen in people who quit nicotine entirely. Meanwhile, those who continued smoking saw their biomarker levels increase slightly. Blood carboxyhemoglobin, a marker of carbon monoxide exposure, dropped by about 72% in switchers, again comparable to the abstinence group.¹⁷

A longer 24-week clinical trial confirmed these patterns. Smokers randomized to switch to e-vapor products showed about a 60% reduction in blood carboxyhemoglobin and roughly 73 to 84% reductions in urinary NNAL, a metabolite strongly linked to tobacco-related cancer risk, compared to baseline. Those who continued smoking showed minimal changes.¹⁸

These numbers are substantial and consistent across studies. They do not prove that nicotine salt devices are “safe” in absolute terms, but they make a strong case that for current smokers, switching completely away from combustible cigarettes to a nicotine salt product dramatically reduces exposure to the most dangerous known toxicants in tobacco smoke. The key word is “completely.” Dual use, smoking some cigarettes while also vaping, erodes much of that benefit.

The Cessation Evidence

A Cochrane systematic review, considered the gold standard for evidence synthesis, found moderate-certainty evidence that people randomized to nicotine e-cigarettes were roughly 69% more likely to quit smoking than those given nicotine replacement therapy like patches or gum. The review specifically noted that newer pod devices using nicotine salt formulations reduce irritant effects and allow delivery of higher nicotine levels that closely mimic the pharmacokinetic profile of cigarettes, despite operating on low battery power.¹⁹ Compared to behavioral support alone or no support, nicotine e-cigarettes roughly doubled or tripled quit rates across multiple trials.

This is where the tension in the nicotine salt debate becomes clearest. The same properties that make these products concerning, the high nicotine delivery, the smooth feel, the cigarette-like pharmacokinetics, are precisely the properties that make them effective cessation tools. A product that does not satisfy a smoker’s craving will not help them quit, and nicotine salts satisfy cravings in a way that older e-cigarette formulations and nicotine patches often do not.

Oral Health Concerns

The mouth is the first point of contact for e-cigarette aerosol, and emerging evidence suggests that regular vaping affects the oral environment in ways that may raise the risk of gum disease. E-cigarette aerosols containing nicotine and humectants break down into reactive oxygen species and carbonyls that cause oxidative stress in oral tissues. Vaping appears to promote dry mouth and shift the pH of oral surfaces, which triggers changes in the bacterial community. In this altered environment, bacteria can use propylene glycol and vegetable glycerin as a carbon source, favoring the growth of anaerobic species while suppressing beneficial ones. The aerosols also enhance the ability of certain harmful bacteria to form biofilms, while impairing the host immune response that would normally keep those bacteria in check.

These findings are relatively new and mostly based on laboratory and animal models. Long-term clinical data on how nicotine salt vaping specifically affects periodontal health in humans are still scarce. But the early evidence points toward a plausible pathway from chronic vaping to oral microbiome disruption and eventually to deeper periodontal probing depths, which is a clinical sign of gum disease progression.

Regulatory Landscape

The regulatory approach to nicotine salts varies sharply across jurisdictions. In the European Union, the Tobacco Products Directive caps nicotine concentration at 20 mg/mL for all e-liquids, effectively limiting how much nicotine a salt-based product can deliver per puff in that market.²⁰ The United States has no equivalent federal cap on nicotine concentration, though the FDA requires premarket authorization for e-cigarette products. In practice, nicotine salt products at 50 mg/mL or higher remain widely available in the U.S., both in authorized and unauthorized products.

The EU’s 20 mg/mL ceiling is a blunt instrument, but it does something that U.S. regulation currently does not: it places a hard limit on the nicotine payload per puff, which constrains both the addictive potential and the speed of dependence development. Whether that limit is set at the right level is debated, since some researchers argue it may be too low to help heavy smokers switch effectively, while others see it as a reasonable precaution against youth uptake.

Pregnancy and Fetal Development

One area where the evidence tilts strongly toward caution is pregnancy. In a mouse study, maternal exposure to e-cigarette aerosols containing nicotine, whether starting before conception or only during gestation, significantly decreased offspring birth weight and body length. The preconception exposure group showed downregulation of inflammation-related genes in both dams and fetuses, suggesting an immunosuppressive effect. Lung tissue in exposed offspring showed structural abnormalities at birth, supported by downregulation of 75 genes in the Wnt signaling pathway, which is critical for normal lung development.²¹

This is animal data, and mouse lung development does not map perfectly onto human pregnancy. But the findings are consistent with decades of research showing that nicotine exposure during fetal development, regardless of delivery method, harms developing organs. For pregnant individuals, no form of nicotine is considered safe, and nicotine salts are no exception. The fact that salt-based devices deliver nicotine at higher concentrations than older e-cigarettes makes this concern more pressing, not less.

Pulmonary Surfactant Damage

A less widely discussed risk involves pulmonary surfactant, the thin layer of material that coats the inside of your lungs and keeps the air sacs from collapsing. When researchers exposed pulmonary surfactant to e-cigarette aerosol, the surfactant’s ability to reduce surface tension was significantly impaired across multiple compression cycles. Interestingly, mixing the non-aerosolized e-liquid with surfactant did not cause the same damage, suggesting it is something about the aerosolization process, the heat-generated byproducts, that does the harm. Certain flavors, particularly menthol, caused additional surfactant impairment beyond the base aerosol.²² Whether nicotine itself was present or absent made no additional difference in that study, which underscores that not all vaping-related lung harm traces back to nicotine. The heated carrier fluids and flavorings contribute independently.